BACKGROUND: The aim of this study was to analyze the treatment results of fungal periprosthetic joint infections (PJI) caused by Candida species from a single orthopedic center and to compare them with reports from other institutions. METHODS: Eight patients operated on from January 2014 to December 2021 met the inclusion criteria and were analyzed in terms of clinical outcomes. A systematic review of the literature identified 153 patients with Candida PJIs extracted from 12 studies according to the PRISMA (Preferred Reporting Item for Systematic Reviews and Meta-Analyses) guidelines. RESULTS: The success rate of the treatment in the case series was 50%. The most frequent pathogens were Candida albicans (three cases; 37.5%) and Candida parapsilosis (three cases; 37.5%). In one patient (12.5%), bacterial co-infection was noted, and in five patients (62.5%) significant risk factors of PJI were confirmed. The overall success rate on the basis of data collected for systematic review was 65.5%. A sub-analysis of 127 patients revealed statistically significant differences (p = 0.02) with a higher success rate for the knees (77.6%) than for the hips (58%). In 10 studies the analysis of risk factors was performed and among 106 patients in 77 (72.6%) comorbidities predispose to fungal PJI were confirmed. Bacterial co-infection was noted in 84 patients (54.9%). In 93 patients (60.7%) Candida albicans was the culprit pathogen, and in 39 patients (25.5%) Candida parapsilosis was the culprit pathogen. Based on these two most frequent Candida species causing PJI, the success rate of the treatment was statistically different (p = 0.03), and was 60.3% and 83.3%, respectively. The two-stage strategy was more favorable for patients with Candida parapsilosis infections (94.4% success rate) than the one-stage protocol (50% success rate; p = 0.02); as well as in comparison to the two-stage treatment of Candida albicans (65% success rate; p = 0.04). CONCLUSIONS: The analysis of the literature showed no differences in the overall success rate between one- and two-stage surgical strategies for all Candida species, but differed significantly comparing the two most frequent strains and concerning PJI localization. The frequent presence of bacterial co-infections makes it necessary to consider the additional administration of antibiotics in the case of fungal PJI.

1st Department of Orthopaedics 1st Faculty of Medicine of Charles University and Motol University Hospital 5 Uvalu 84 15006 Prague Czech Republic

Central Laboratory of Professor Adam Gruca Orthopedic and Trauma Teaching Hospital Konarskiego 13 05 400 Otwock Poland

Department of Anatomical Dissection and Donation Medical University of Lodz Żeligowskiego 7 9 90 752 Lodz Poland

Department of Orthopedics and Rheumoorthopedics Centre of Postgraduate Medical Education Professor Adam Gruca Orthopedic and Trauma Teaching Hospital Konarskiego 13 05 400 Otwock Poland

Department of Spine Diseases and Orthopedics Centre of Postgraduate Medical Education Professor Adam Gruca Orthopedic and Trauma Teaching Hospital Konarskiego 13 05 400 Otwock Poland

See more in PubMed

Brown T.S., Petis S.M., Osmon D.R., Mabry T.M., Berry D.J., Hanssen A.D., Abdel M.P. Periprosthetic Joint Infection with Fungal Pathogens. J. Arthroplast. 2018;33:2605–2612. doi: 10.1016/j.arth.2018.03.003. PubMed DOI

Maertens J., Vrebos M., Boogaerts M. Assessing risk factors for systemic fungal infections. Eur. J. Cancer Care. 2001;10:56–62. doi: 10.1046/j.1365-2354.2001.00241.x. PubMed DOI

Yang S.-P., Chen Y.-Y., Hsu H.-S., Wang F.-D., Chen L.-Y., Fung C.-P. A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: A retrospective cohort study. BMC Infect. Dis. 2013;13:10. doi: 10.1186/1471-2334-13-10. PubMed DOI PMC

Kelesidis T., Tsiodras S. Candida albicans prosthetic hip infection in elderly patients: Is fluconazole monotherapy an option? Scand. J. Infect. Dis. 2010;42:12–21. doi: 10.3109/00365540903253510. PubMed DOI PMC

Bosshard P.P. Incubation of fungal cultures: How long is long enough? Mycoses. 2011;54:e539–e545. doi: 10.1111/j.1439-0507.2010.01977.x. PubMed DOI

Azzam K., Parvizi J., Jungkind D., Hanssen A., Fehring T., Springer B., Bozic K., Della Valle C., Pulido L., Barrack R. Microbiological, Clinical, and Surgical Features of Fungal Prosthetic Joint Infections: A Multi-Institutional Experience. J. Bone Jt. Surg. 2009;91((Suppl. S6)):142–149. doi: 10.2106/JBJS.I.00574. PubMed DOI

Gross C.E., Della Valle C.J., Rex J.C., Traven S.A., Durante E.C. Fungal Periprosthetic Joint Infection: A Review of Demographics and Management. J. Arthroplast. 2021;36:1758–1764. doi: 10.1016/j.arth.2020.11.005. PubMed DOI

Escolà-Vergé L., Rodríguez-Pardo D., Lora-Tamayo J., Morata L., Murillo O., Vilchez H., Sorli L., Carrión L.G., Barbero J.M., Palomino-Nicás J., et al. Candida periprosthetic joint infection: A rare and difficult-to-treat infection. J. Infect. 2018;77:151–157. doi: 10.1016/j.jinf.2018.03.012. PubMed DOI

Jenny J.Y., Goukodadja O., Boeri C., Gaudias J. May one-stage exchange for Candida albicans peri-prosthetic infection be successful? Orthop. Traumatol. Surg. Res. 2016;102:127–129. doi: 10.1016/j.otsr.2015.10.001. PubMed DOI

Wang Q.J., Shen H., Zhang X.-L., Jiang Y., Wang Q., Chen Y.S., Shao J.-J. Staged reimplantation for the treatment of fungal peri-prosthetic joint infection following primary total knee arthro-plasty. Orthop. Traumatol. Surg. Res. 2015;101:151–156. doi: 10.1016/j.otsr.2014.11.014. PubMed DOI

Koutserimpas C., Samonis G., Velivassakis E., Iliopoulou-Kosmadaki S., Kontakis G., Kofteridis D.P. Candida glabrata prosthetic joint infection, successfully treated with anidulafungin: A case report and review of the literature. Mycoses. 2017;61:266–269. doi: 10.1111/myc.12736. PubMed DOI

Kim J.-K., Lee D.-Y., Kang D.-W., Ro D.-H., Lee M.C., Han H.-S. Efficacy of antifungal-impregnated cement spacer against chronic fungal periprosthetic joint infections after total knee arthroplasty. Knee. 2018;25:631–637. doi: 10.1016/j.knee.2018.04.004. PubMed DOI

Riaz T., Tande A.J., Steed L.L., Demos H.A., Salgado C.D., Osmon D.R., Marculescu C.E. Risk Factors for Fungal Prosthetic Joint Infection. J. Bone Jt. Infect. 2020;5:76–81. doi: 10.7150/jbji.40402. PubMed DOI PMC

Hwang B.-H., Yoon J.-Y., Nam C.-H., Jung K.-A., Lee S.-C., Han C.-D., Moon S.-H. Fungal peri-prosthetic joint infection after primary total knee replacement. J. Bone Jt. Surg. Br. 2012;94:656–659. doi: 10.1302/0301-620X.94B5.28125. PubMed DOI

Escola-Verge L., Rodríguez-Pardo D., Corona P.S., Pigrau C. Candida Periprosthetic Joint Infection: Is It Curable? Antibiotics. 2021;10:458. doi: 10.3390/antibiotics10040458. PubMed DOI PMC

Jakobs O., Schoof B., Klatte T.O., Schmidl S., Fensky F., Guenther D., Frommelt L., Gehrke T., Gebauer M. Fungal periprosthetic joint infection in total knee arthroplasty: A systematic review. Orthop. Rev. 2015;7:5623. doi: 10.4081/or.2015.5623. PubMed DOI PMC

Fusini F., Aprato A., Massè A., Bistolfi A., Girardo M., Artiaco S. Candida periprosthetic infection of the hip: A systematic review of surgical treatments and clinical outcomes. Int. Orthop. 2020;44:15–22. doi: 10.1007/s00264-019-04369-z. PubMed DOI

Gao Z., Li X., Du Y., Peng Y., Wu W., Zhou Y. Success Rate of Fungal Peri-Prosthetic Joint Infection Treated by 2-Stage Revision and Potential Risk Factors of Treatment Failure: A Retrospective Study. Med. Sci. Monit. 2018;24:5549–5557. doi: 10.12659/MSM.909168. PubMed DOI PMC

Kuo F.-C., Goswami K., Shohat N., Blevins K., Rondon A.J., Parvizi J. Two-Stage Exchange Arthroplasty Is a Favorable Treatment Option Upon Diagnosis of a Fungal Periprosthetic Joint Infection. J. Arthroplast. 2018;33:3555–3560. doi: 10.1016/j.arth.2018.07.024. PubMed DOI

Belden K., Cao L., Chen J., Deng T., Fu J., Guan H., Jia C., Kong X., Kuo F.-C., Li R., et al. Hip and Knee Section, Fungal Periprosthetic Joint Infection, Diagnosis and Treatment: Proceedings of International Consensus on Orthopedic Infections. J. Arthroplast. 2018;34((Suppl. S2)):S387–S391. doi: 10.1016/j.arth.2018.09.023. PubMed DOI

Ji B., Zhang X., Xu B., Guo W., Mu W., Cao L. Single-Stage Revision for Chronic Fungal Periprosthetic Joint Infection: An Average of 5 Years of Follow-Up. J. Arthroplast. 2017;32:2523–2530. doi: 10.1016/j.arth.2017.03.030. PubMed DOI

Klatte T.O., Kendoff D., Kamath A.F., Jonen V., Rueger J.M., Frommelt L., Gebauer M., Gehrke T. Single-stage revision for fungal peri-prosthetic joint infection: A single-centre experience. Bone Jt. J. 2014;96:492–496. doi: 10.1302/0301-620X.96B4.32179. PubMed DOI

Enz A., Mueller S., Warnke P., Ellenrieder M., Mittelmeier W., Klinder A. Periprosthetic Fungal Infections in Severe Endoprosthetic Infections of the Hip and Knee Joint—A Retrospective Analysis of a Certified Arthroplasty Centre of Excellence. J. Fungi. 2021;7:404. doi: 10.3390/jof7060404. PubMed DOI PMC

Karczewski D., Ren Y., Andronic O., Akgün D., Perka C., Müller M., Kienzle A. Candida periprosthetic joint infections—Risk factors and outcome between albicans and non-albicans strains. Int. Orthop. 2022;46:449–456. doi: 10.1007/s00264-021-05214-y. PubMed DOI PMC

Saconi E.S., de Carvalho V.C., de Oliveira P.R.G., Lima A.L.L.M. Prosthetic joint infection due to Candida species: Case series and review of literature. Medicine. 2020;99:e19735. doi: 10.1097/MD.0000000000019735. PubMed DOI PMC

Theil C., Schmidt-Braekling T., Gosheger G., Idelevich E.A., Moellenbeck B., Dieckmann R. Fungal prosthetic joint infection in total hip or knee arthroplasty: A retrospective single-centre study of 26 cases. Bone Jt. J. 2019;101:589–595. doi: 10.1302/0301-620X.101B5.BJJ-2018-1227.R2. PubMed DOI

Lee Y.R., Kim H.J., Lee E.J., Sohn J.W., Kim M.J., Yoon Y.K. Prosthetic Joint Infections Caused by Candida Species: A Systematic Review and a Case Series. Mycopathologia. 2019;184:23–33. doi: 10.1007/s11046-018-0286-1. PubMed DOI

Parvizi J., Gehrke T., Chen A.F. Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Jt. J. 2013;95:1450–1452. doi: 10.1302/0301-620X.95B11.33135. PubMed DOI

Parvizi J., Tan T.L., Goswami K., Higuera C., Della Valle C., Chen A.F., Shohat N. The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. J. Arthroplast. 2018;33:1309–1314.e2. doi: 10.1016/j.arth.2018.02.078. PubMed DOI

Diaz-Ledezma C., Higuera C.A., Parvizi J. Success After Treatment of Periprosthetic Joint Infection: A Delphi-based International Multidisciplinary Consensus. Clin. Orthop. Relat. Res. 2013;471:2374–2382. doi: 10.1007/s11999-013-2866-1. PubMed DOI PMC

Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71. PubMed DOI PMC

Darouiche R.O., Hamill R.J., Musher D.M., Young E.J., Harris R.L. Periprosthetic Candidal Infections Following Arthroplasty. Clin. Infect. Dis. 1989;11:89–96. doi: 10.1093/clinids/11.1.89. PubMed DOI

Phelan D.M., Osmon D.R., Keating M.R., Hanssen A.D. Delayed Reimplantation Arthroplasty for Candidal Prosthetic Joint Infection: A Report of 4 Cases and Review of the Literature. Clin. Infect. Dis. 2002;34:930–938. doi: 10.1086/339212. PubMed DOI

Dutronc H., Dauchy F.A., Cazanave C., Rougie C., Lafarie-Castet S., Couprie B., Fabre T., Dupon M. Candida prosthetic infections: Case series and literature review. Scand. J. Infect. Dis. 2010;42:890–895. doi: 10.3109/00365548.2010.498023. PubMed DOI

Ueng S.W.N., Lee C.-Y., Hu C.-C., Hsieh P.-H., Chang Y. What is the success of treatment of hip and knee candidal periprosthetic joint infection? Clin. Orthop. Relat. Res. 2013;471:3002–3009. doi: 10.1007/s11999-013-3007-6. PubMed DOI PMC

Kuiper J.W.P., van den Bekerom M.P.J., van der Stappen J., Nolte P.A., Colen S. 2-stage revision recommended for treatment of fungal hip and knee prosthetic joint infections. Acta Orthop. 2013;84:517–523. doi: 10.3109/17453674.2013.859422. PubMed DOI PMC